• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群失调可导致肾结石病。

Intestinal dysbacteriosis leads to kidney stone disease.

机构信息

Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China.

出版信息

Mol Med Rep. 2021 Mar;23(3). doi: 10.3892/mmr.2020.11819. Epub 2020 Dec 31.

DOI:10.3892/mmr.2020.11819
PMID:33655334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809898/
Abstract

The formation and physicochemical properties of kidney stones (KSs) are closely associated with diet. In view of the differences in ethnicity and dietary composition between Chinese and Western populations, the present study aimed to investigate the association between intestinal dysbacteriosis and KSs in China. The current study examined the differences in intestinal microbes between the KS disease (KSD) and the healthy control (HLT) groups, and statistically significant differences based on 16s rRNA gene amplicons were identified using a Student's t‑test or one‑way ANOVA. In addition, the calcium oxalate KS (COKS), uric acid KS (UAKS) and carbonate apatite KS(CCKS) groups were compared with a non‑parametric statistical test. Determination of bacterial abundance was performed via the analysis of 16s rRNA marker gene sequences using next‑generation sequencing. Firmicutes (F) and Bacteroides (B) levels were significantly higher in the KSD group compared with the HLT group (B/F=0.67 vs. 0.08; P<0.001), as were the overall levels of B (6.19‑fold higher compared with the HLT group; 22.2 vs. 3.6%; P<0.001). The Prevotella‑9 abundance levels in the KSD group were 4.65‑fold higher compared with those in the HLT group (8.8 vs. 1.9%; P<0.001). The levels of Blautia and Lachnoclostridium were significantly decreased in the KSD group (13.3 vs. 6.0%; and 5.0 vs. 7.9%; both P<0.05). Moreover, Prevotella‑9 levels were higher in non‑calciferous KSs (UAKS) compared with calciferous KSs (COKS and CCKS). Therefore, the findings of the present study indicated a key association between specific KS components and intestinal flora, providing a theoretical basis for new treatment methods for KSs. Moreover, differences and interactions between these bacteria could initially predict specific types of urolithiasis.

摘要

肾结石(KSs)的形成和理化性质与饮食密切相关。鉴于中西方人群在种族和饮食组成上存在差异,本研究旨在探讨中国肠菌失调与 KSs 之间的关系。本研究检测了 KS 疾病(KSD)与健康对照组(HLT)之间肠道微生物的差异,并通过学生 t 检验或单向方差分析比较了基于 16s rRNA 基因扩增子的统计学差异。此外,还对草酸钙 KS(COKS)、尿酸 KS(UAKS)和碳酸磷灰石 KS(CCKS)组进行了非参数统计检验。通过下一代测序分析 16s rRNA 标记基因序列来确定细菌丰度。Firmicutes(F)和Bacteroides(B)在 KSD 组中的水平明显高于 HLT 组(B/F=0.67 比 0.08;P<0.001),B 的总体水平也明显高于 HLT 组(高 6.19 倍;22.2 比 3.6%;P<0.001)。KSD 组中Prevotella-9的丰度水平比 HLT 组高 4.65 倍(8.8 比 1.9%;P<0.001)。KSD 组中Blautia和Lachnoclostridium的水平明显降低(13.3 比 6.0%;和 5.0 比 7.9%;均 P<0.05)。此外,Prevotella-9的水平在非钙性 KSs(UAKS)中高于钙性 KSs(COKS 和 CCKS)。因此,本研究的结果表明,特定 KS 成分与肠道菌群之间存在重要关联,为 KS 新的治疗方法提供了理论依据。此外,这些细菌之间的差异和相互作用可以初步预测特定类型的尿石症。

相似文献

1
Intestinal dysbacteriosis leads to kidney stone disease.肠道菌群失调可导致肾结石病。
Mol Med Rep. 2021 Mar;23(3). doi: 10.3892/mmr.2020.11819. Epub 2020 Dec 31.
2
Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.与非肾结石患者相比,肾结石患者存在独特肠道微生物群的证据。
Urolithiasis. 2016 Oct;44(5):399-407. doi: 10.1007/s00240-016-0882-9. Epub 2016 Apr 26.
3
The Role of the Gut Microbiome in Kidney Stone Disease.肠道微生物组在肾结石病中的作用。
Urol Clin North Am. 2024 Nov;51(4):475-482. doi: 10.1016/j.ucl.2024.06.003. Epub 2024 Aug 17.
4
Deficient butyrate metabolism in the intestinal microbiome is a potential risk factor for recurrent kidney stone disease.肠道微生物组丁酸代谢不足是复发性肾结石病的一个潜在危险因素。
Urolithiasis. 2024 Feb 28;52(1):38. doi: 10.1007/s00240-024-01534-x.
5
Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.高草酸尿症导致肠道菌群失调,并选择性富集草酸代谢细菌物种,从而促进复发性肾结石的发生。
Sci Rep. 2016 Oct 6;6:34712. doi: 10.1038/srep34712.
6
Intestinal dysbacteriosis mediates the reference memory deficit induced by anaesthesia/surgery in aged mice.肠道菌群失调介导麻醉/手术引起的老年小鼠参考记忆缺陷。
Brain Behav Immun. 2019 Aug;80:605-615. doi: 10.1016/j.bbi.2019.05.006. Epub 2019 May 4.
7
Association of dietary patterns with gut microbiota in kidney stone and non-kidney stone individuals.饮食模式与肾结石和非肾结石个体肠道微生物群的关联。
Urolithiasis. 2022 Aug;50(4):389-399. doi: 10.1007/s00240-022-01325-2. Epub 2022 Apr 23.
8
16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones.16S rRNA 基因测序揭示肾结石患者肠道微生物群落组成的改变。
Urolithiasis. 2018 Nov;46(6):503-514. doi: 10.1007/s00240-018-1037-y. Epub 2018 Jan 20.
9
Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.基于粪便代谢组学联合 16S rRNA 基因测序分析肾阳虚证大鼠肠道菌群变化及右归丸的干预作用
J Ethnopharmacol. 2019 Nov 15;244:112139. doi: 10.1016/j.jep.2019.112139. Epub 2019 Aug 8.
10
Characteristics of the urinary microbiome in kidney stone patients with hypertension.高血压肾结石患者尿液微生物群的特征
J Transl Med. 2020 Mar 17;18(1):130. doi: 10.1186/s12967-020-02282-3.

引用本文的文献

1
Dysbiosis of gut and urinary microbiota in urolithiasis patients and post-surgical cases.尿路结石患者及术后病例中肠道和泌尿微生物群的失调
Front Cell Infect Microbiol. 2025 Aug 13;15:1633783. doi: 10.3389/fcimb.2025.1633783. eCollection 2025.
2
Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker.衰老相关疾病中的细胞外囊泡:疾病发病机制、干预措施及生物标志物
Stem Cell Res Ther. 2025 May 28;16(1):263. doi: 10.1186/s13287-025-04374-7.
3
Lifestyle Factors and the Microbiome in Urolithiasis: A Narrative Review.

本文引用的文献

1
Understanding the Link Between Gut Microbiome and Urinary Stone Disease.了解肠道微生物组与尿路结石病之间的联系。
Curr Urol Rep. 2019 Mar 22;20(5):19. doi: 10.1007/s11934-019-0882-8.
2
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).肠道微生物群衍生的短链脂肪酸(SCFAs)的免疫调节潜力。
Acta Biochim Pol. 2019 Mar 4;66(1):1-12. doi: 10.18388/abp.2018_2648.
3
Perceptions of dietary factors promoting and preventing nephrolithiasis: a cross-sectional survey.促进和预防肾结石的饮食因素认知:一项横断面调查。
尿路结石中的生活方式因素与微生物群:一篇叙述性综述。
Nutrients. 2025 Jan 27;17(3):465. doi: 10.3390/nu17030465.
4
Multiomics analyses reveal adipose-derived stem cells inhibit the inflammatory response of M1-like macrophages through secreting lactate.多组学分析表明,脂肪来源干细胞通过分泌乳酸来抑制M1样巨噬细胞的炎症反应。
Stem Cell Res Ther. 2024 Dec 18;15(1):485. doi: 10.1186/s13287-024-04072-w.
5
Effect of konjac glucomannan on gut microbiota from hyperuricemia subjects : fermentation characteristics and inhibitory xanthine oxidase activity.魔芋葡甘聚糖对高尿酸血症患者肠道微生物群的影响:发酵特性及抑制黄嘌呤氧化酶活性
Front Nutr. 2024 Sep 19;11:1465940. doi: 10.3389/fnut.2024.1465940. eCollection 2024.
6
Unraveling the association of bacteria and urinary stones in patients with urolithiasis: an update review article.解析尿路结石患者中细菌与尿路结石的关联:一篇最新综述文章。
Front Med (Lausanne). 2024 Aug 30;11:1401808. doi: 10.3389/fmed.2024.1401808. eCollection 2024.
7
Gut and Urinary Microbiota in Cats with Kidney Stones.患有肾结石的猫的肠道和泌尿微生物群
Microorganisms. 2024 May 29;12(6):1098. doi: 10.3390/microorganisms12061098.
8
Urolithiasis Problems in Finishing Pigs.育肥猪的尿石症问题
Vet Sci. 2023 Dec 3;10(12):688. doi: 10.3390/vetsci10120688.
9
Causal Relationship between Gut Microbiota and Gout: A Two-Sample Mendelian Randomization Study.肠道微生物群与痛风的因果关系:两样本孟德尔随机化研究。
Nutrients. 2023 Oct 5;15(19):4260. doi: 10.3390/nu15194260.
10
The emerging role of the urinary microbiome in benign noninfectious urological conditions: an up-to-date systematic review.尿微生物组在良性非传染性泌尿科疾病中的新兴作用:最新系统评价。
World J Urol. 2023 Nov;41(11):2933-2948. doi: 10.1007/s00345-023-04588-5. Epub 2023 Sep 22.
World J Urol. 2019 Aug;37(8):1723-1731. doi: 10.1007/s00345-018-2562-6. Epub 2018 Dec 15.
4
Genetics of common complex kidney stone disease: insights from genome-wide association studies.常见复杂肾结石病的遗传学:全基因组关联研究的启示。
Urolithiasis. 2019 Feb;47(1):11-21. doi: 10.1007/s00240-018-1094-2. Epub 2018 Dec 6.
5
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.肠道微生物群作为2型糖尿病高血糖预防和治疗的靶点:从当前的人类证据到未来的可能性
Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22.
6
Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort.METSIM队列中肠道微生物群、血浆代谢物与代谢综合征特征之间的关系。
Genome Biol. 2017 Apr 13;18(1):70. doi: 10.1186/s13059-017-1194-2.
7
Accurate stone analysis: the impact on disease diagnosis and treatment.精准的结石分析:对疾病诊断与治疗的影响。
Urolithiasis. 2017 Feb;45(1):3-9. doi: 10.1007/s00240-016-0943-0. Epub 2016 Dec 3.
8
Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.高草酸尿症导致肠道菌群失调,并选择性富集草酸代谢细菌物种,从而促进复发性肾结石的发生。
Sci Rep. 2016 Oct 6;6:34712. doi: 10.1038/srep34712.
9
Human gut microbes impact host serum metabolome and insulin sensitivity.人体肠道微生物影响宿主血清代谢组和胰岛素敏感性。
Nature. 2016 Jul 21;535(7612):376-81. doi: 10.1038/nature18646. Epub 2016 Jul 13.
10
Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.与非肾结石患者相比,肾结石患者存在独特肠道微生物群的证据。
Urolithiasis. 2016 Oct;44(5):399-407. doi: 10.1007/s00240-016-0882-9. Epub 2016 Apr 26.